minoxidil and finasteride

minoxidil has been researched along with finasteride in 161 studies

Research

Studies (161)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's18 (11.18)18.2507
2000's46 (28.57)29.6817
2010's48 (29.81)24.3611
2020's49 (30.43)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brunden, MN; Buhl, AE; Diani, AR; Johnson, GA; Kubicek, MF; Mulholland, MJ; Schostarez, HJ; Shull, KL1
Dunn, CL; James, WD; Walsh, DS1
Rand, S1
Piérard, GE; Piérard-Franchimont, C1
Davies, K1
Price, VH; Shapiro, J1
Aubin, F; Esteve, E1
Bergfeld, WF1
Sinclair, R1
Sinclair, RD; Tran, D1
Nolte, RS; Scow, DT; Shaughnessy, AF1
Piraccini, BM; Tosti, A1
Price, VH2
Sawaya, M1
Cash, TF1
Barth, JH1
Kunte, C; Wolff, H1
Wasielewski, S1
Chamberlain, M; Hogan, DJ1
Saiag, P1
Granel, F1
Messenger, AG1
Meidan, VM; Touitou, E1
Patel, JC1
de Viragh, PA; Trüeb, RM1
Sinclair, RD1
Sawaya, ME1
Olsen, EA1
Hannuksela, M1
Bader, U; Trüeb, RM1
Khandpur, S; Reddy, BS; Suman, M1
Avram, MR; Cole, JP; Gandelman, M; Haber, R; Knudsen, R; Leavitt, MT; Leonard, RT; Puig, CJ; Rose, PT; Vogel, JE; Ziering, CL1
Hoffmann, R1
Hanneken, S; Kruse, R; Nöthen, MM; Ritzmann, S1
Kumar, B; Saraswat, A1
Iorizzo, M; Tosti, A; Vincenzi, C1
Trüeb, RM1
Ellis, JA; Harrap, SB; Sinclair, R1
Bouhanna, P1
Bandaranayake, I; Mirmirani, P1
Haber, RS1
Açikgöz, G; Arca, E; Köse, O; Kurumlu, Z; Taştan, HB1
Itami, S2
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA1
Bienová, M; Fiurásková, M; Hajdúch, M; Koláŕ, Z; Kucerová, R1
Simon, HB1
Haber, R; Parsley, WM; Stenn, K; Stough, D; Vogel, JE; Washenik, K; Whiting, DA1
Camacho Martínez, F; Moreno-Ramírez, D1
Epstein, JS1
Tsiskarishvili, NV; Tsiskarishvili, TsI1
Finner, AM; Otberg, N; Shapiro, J1
Avram, MR; Rogers, NE2
Scheinfeld, N1
Alsantali, A; Shapiro, J1
Duque-Estrada, B; Piraccini, BM; Sisti, A; Tosti, A1
Karamanovski, E; Lam, SM1
Cantatore-Francis, J; Gonzalez, ME; Orlow, SJ1
Rathnayake, D; Sinclair, R1
Ghanaat, M1
Jandali, S; Low, DW1
McDonough, PH; Schwartz, RA1
Dawson, TL; Patel, M; Perez, A; Rufaut, NW; Sinclair, R; Yazdabadi, A; Yip, L1
Inui, S; Itami, S; Katsuoka, K; Kono, T; Kurata, S; Manabe, M; Saito, N; Tsuboi, R; Ueki, R; Yamazaki, M1
Bergstrom, KG1
McElwee, KJ; Shapiro, JS1
Banka, N; Bunagan, MJ; Shapiro, J1
Tanglertsampan, C1
Basra, MK; Bhatti, HA; Patel, GK1
Nusbaum, AG; Nusbaum, BP; Rose, PT1
Ferreira, D; Gomes, MJ; Martins, S; Reis, S; Segundo, MA1
Bergfeld, WF; Varothai, S1
Bechtel, MA; Harfmann, KL1
Danesh, M; Murase, JE1
Goodier, M; Hordinsky, M1
Torres, F1
Ioannides, D; Lazaridou, E1
Wolff, H1
Vary, JC1
Hugh Rushton, D; Norris, MJ; Van Neste, D1
Fedorowicz, Z; Schoones, J; van Zuuren, EJ1
Hwang, ST; Jung, JH; Kim, JC; Lee, IJ; Lee, YR1
Anzalone, A; Carlesimo, M; Caro, G; Fortuna, MC; Garelli, V; Pranteda, G; Rossi, A1
Blume-Peytavi, U; Fischer, TW; Wolff, H1
Blanco, A; Kelly, Y; Tosti, A1
Li, Q; Wu, M; Yu, Q1
Reygagne, P1
Fedorowicz, Z; van Zuuren, EJ1
Adil, A; Godwin, M1
Alves, R; Grimalt, R1
Baek, SY; Kang, G; Kang, H; Kim, J; Kim, NS; Lee, JH; Park, HN; Park, S; Park, SK1
Blume-Peytavi, U; Blumeyer, A; Del Marmol, V; Dobos, G; Finner, A; Kanti, V; Messenger, A; Nast, A; Piraccini, BM; Reygagne, P; Tosti, A; Trakatelli, M1
Baek, SY; Kang, H; Lee, JH; Lee, YM; Park, HN; Park, SK1
Dotzert, MS; Gupta, AK; Mays, RR; Piguet, V; Shear, NH; Versteeg, SG1
Amoh, Y; Inui, S; Itami, S; Ito, T; Kono, T; Kurata, S; Manabe, M; Nakamura, M; Narusawa, H; Ohyama, M; Osada, SI; Saito, N; Sato, A; Shimomura, Y; Tsuboi, R; Ueki, R; Yamazaki, M1
Anitua, E; Jaén, P; Navarro, MR; Pino, A1
Chalermroj, N; Khunkhet, S; Srisuwanwattana, P; Suchonwanit, P1
Iamsumang, W; Rojhirunsakool, S; Suchonwanit, P1
Andy, G; Aseem, S; John, M; Maja, K; Michael, K; Mirna, S; Rachita, D; Zeljana, B1
Araujo, LR; de Mattos Barreto, T; Melo, DF; Plata, GT; Tortelly, VD1
Asnaashari, S; Javadzadeh, Y1
Beck, R; da Silva, C; Katzer, T; Leite Junior, A1
Burroway, B; Griggs, J; Tosti, A1
Fernandez-Nieto, D; Jimenez-Cauhe, J; Moreno-Arrones, OM; Ortega-Quijano, D; Saceda-Corralo, D; Vaño-Galvan, S1
Pirmez, R; Salas-Callo, CI1
Van Neste, D1
Bhoyrul, B; Meah, N; Sinclair, R; York, K1
Marks, DH; Senna, MM1
Chen, B; Chen, L; Wang, H; Wang, L; Zhang, J1
Bamimore, MA; Foley, KA; Gupta, AK1
Garcovich, S; Gentile, P1
Kochhar, A; Tai, T1
Chen, G; Gu, Z; Yang, G1
Chen, C; Fan, Z; Hu, Z; Miao, Y; Qu, Q; Wang, J; Zhang, C; Zhou, Y1
Cinelli, E; Fabbrocini, G; Ocampo-Candiani, J; Ocampo-Garza, SS; Villani, A1
Makki, M; Salah, I; Younes, AH1
Amin, PD; Jha, DK; Shah, DS1
Jianmongkol, S; Ngampanya, A; Ongpipattanakul, B; Patel, N; Pornputtapong, N; Prueksaritanont, T; Sermsappasuk, P; Udomnilobol, U1
Doshi, K; Kapoor, R; Kumar, V; Patel, G; Shome, D; Vadera, S1
Rose, PT1
Ablon, G; Fischer, DL; Gade, A; Han, H; Nestor, MS1
Dommasch, ED; Gao, JL; Peebles, JK; Streed, CG; Thompson, J1
Carla Jorge, M; de Barros, CC; de Melo Carvalho, R; Melo, DF; Saceda-Corralo, D; Starace, M; Tosti, A; Weffort, F1
Liu, C; Wu, W; Zhang, Y; Zhao, H1
Bamimore, MA; Gupta, AK; Talukder, M1
Bamimore, MA; Gupta, AK; Talukder, M; Venkataraman, M1
Faghihi, G; Hoseyni, MS; Iraji, F; Jelvan, M; Saber, M; Siadat, AH1
Gupta, AK; Talukder, M1
Gómez-Flores, M; Herz-Ruelas, ME; Martínez-Moreno, A; Ocampo-Candiani, J; Ocampo-Garza, J; Ocampo-Garza, SS; Orizaga-Y-Quiroga, TL; Sánchez-Meza, E1
Gao, S; Jia, Z; Li, K; Tian, K; Wu, L; Xu, W1
Gupta, AK; Talukder, M; Williams, G1
Sand, J; Walen, S2
de Dios Berna-Rico, E; Fernandez-Nieto, D; Hermosa-Gelbard, A; Jimenez-Cauhe, J; Moreno-Arrones, OM; Ortega-Quijano, D; Pindado-Ortega, C; Saceda-Corralo, D; Vaño-Galvan, S1
Domínguez-Santas, M; Grimalt, R; Saceda-Corralo, D; Vañó-Galván, S1
Mahajan, C; Shapiro, J; Tosti, A; Young, PC1
Arruda, S; Haddad, N; Sadick, N1
Chen, G; Fu, Q; Jia, L; Li, N; Zhou, D; Zhou, Y1
Gomes, TF; Soares, RO1
Behrangi, E; Ghassemi, M; Goodarzi, A; Nikkhah, F; Nobari, NN; Roohaninasab, M; Sadeghzadeh-Bazargan, A1
Beley, N; Bjørklund, G; Fedorovska, M; Gasmi, A; Komisarenko, A; Lenchyk, L; Lysiuk, R; Muhammad, A; Mujawdiya, PK; Noor, S; Piscopo, S; Shanaida, M; Strus, O1
Devjani, S; Ezemma, O; Kelley, KJ; Senna, M; Stratton, E1
Abidi, Z; Arruda, S; Rapaport, J; Sadgrove, NJ; Sadick, N; Swearingen, A1
Deoghare, S; Sadick, NS1
Chen, J; Li, Y; Lv, Y; Miao, X; Xiang, H; Xu, S; Xue, X; Zhang, W1
Arruda, S; Farah, RS; Fruechte, S; Hordinsky, MK; Ly, NY; Sadick, N1
Li, Z; Lin, J; Liu, Q; Ni, C; Wang, Q; Wu, W; Yang, K; Zhu, Y1
Da Matta, SLP; Da Silva, J; Gonçalves, RV; Lozi, AA; Santana, FFV1
Hu, L; Luo, F; Zhang, X; Zhao, H1

Reviews

88 review(s) available for minoxidil and finasteride

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Male alopecia: etiopathogenic concepts and current therapies].
    Revue medicale de Liege, 1997, Volume: 52, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Humans; Inflammation; Male; Minoxidil; Severity of Illness Index; Vasodilator Agents

1997
Hair regrowth. Therapeutic agents.
    Dermatologic clinics, 1998, Volume: 16, Issue:2

    Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone

1998
[Androgenetic alopecia].
    Annales de dermatologie et de venereologie, 1997, Volume: 124, Issue:1

    Topics: Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Treatment Outcome; Vasodilator Agents

1997
Male pattern androgenetic alopecia.
    BMJ (Clinical research ed.), 1998, Sep-26, Volume: 317, Issue:7162

    Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Androgens; Antihypertensive Agents; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Minoxidil

1998
Understanding and managing common baldness.
    Australian family physician, 1999, Volume: 28, Issue:3

    Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome

1999
Medical treatments for balding in men.
    American family physician, 1999, Apr-15, Volume: 59, Issue:8

    Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Patient Education as Topic; Severity of Illness Index; Teaching Materials

1999
Androgenetic alopecia.
    International journal of dermatology, 1999, Volume: 38 Suppl 1

    Topics: Alopecia; Female; Finasteride; Humans; Male; Minoxidil

1999
Treatment of hair loss.
    The New England journal of medicine, 1999, Sep-23, Volume: 341, Issue:13

    Topics: 5-alpha Reductase Inhibitors; Administration, Topical; Alopecia; Alopecia Areata; Anthralin; Anti-Inflammatory Agents; Contraindications; Enzyme Inhibitors; Female; Finasteride; Glucocorticoids; Hair; Humans; Immunotherapy; Male; Minoxidil

1999
The psychosocial consequences of androgenetic alopecia: a review of the research literature.
    The British journal of dermatology, 1999, Volume: 141, Issue:3

    Topics: Alopecia; Body Image; Culture; Enzyme Inhibitors; Female; Finasteride; Humans; Interpersonal Relations; Male; Minoxidil; Quality of Life; Self Concept; Vasodilator Agents

1999
Finasteride revisited: Proscar for the prostate and Propecia for the pate.
    Harvard men's health watch, 2000, Volume: 4, Issue:12

    Topics: Adrenergic alpha-Antagonists; Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Prostatic Hyperplasia

2000
[Drug treatment of androgenetic alopecia in men].
    Pharmazie in unserer Zeit, 2000, Volume: 29, Issue:3

    Topics: Adult; Alopecia; Finasteride; Humans; Male; Minoxidil

2000
Male pattern baldness.
    Southern medical journal, 2000, Volume: 93, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Age of Onset; Alopecia; Coronary Disease; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Mental Disorders; Minoxidil; Vasodilator Agents

2000
Medical management of male pattern hair loss.
    International journal of dermatology, 2000, Volume: 39, Issue:8

    Topics: Alopecia; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Minoxidil

2000
Treatments for androgenetic alopecia and alopecia areata: current options and future prospects.
    Drugs, 2001, Volume: 61, Issue:1

    Topics: Adrenal Cortex Hormones; Alopecia; Animals; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Genetic Therapy; Hair Follicle; Humans; Male; Minoxidil; Phytotherapy; Vasodilator Agents

2001
Hair loss.
    Indian journal of medical sciences, 2000, Volume: 54, Issue:3

    Topics: Adult; Alopecia; Child; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; Vasodilator Agents

2000
Management of male pattern hair loss.
    Cutis, 2001, Volume: 68, Issue:1

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Alopecia; Enzyme Inhibitors; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Vasodilator Agents

2001
Baldness. Medical solutions for men and women.
    Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:11

    Topics: Alopecia; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Sex Factors; Vasodilator Agents

2001
Androgenetic alopecia: overview.
    Journal of cutaneous medicine and surgery, 1999, Volume: 3 Suppl 3

    Topics: Alopecia; Androgens; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; Nonprescription Drugs; Sex Characteristics; Skin; Vasodilator Agents

1999
[Loss of hair].
    Duodecim; laaketieteellinen aikakauskirja, 2000, Volume: 116, Issue:7

    Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome

2000
The potential role of minoxidil in the hair transplantation setting.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:10

    Topics: Administration, Oral; Administration, Topical; Alopecia; Combined Modality Therapy; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; Patient Compliance; Vasodilator Agents

2002
[Androgenetic alopecia. Current aspects of a common phenotype].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Disease Progression; Enzyme Inhibitors; Female; Finasteride; Genetic Predisposition to Disease; Hair; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Vasodilator Agents

2003
Androgenetic alopecia: pathogenesis and potential for therapy.
    Expert reviews in molecular medicine, 2002, Nov-19, Volume: 4, Issue:22

    Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Dihydrotestosterone; Female; Finasteride; Genes, Dominant; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Receptors, Androgen

2002
Hair loss remedies--separating fact from fiction.
    Cutis, 2004, Volume: 73, Issue:2

    Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents

2004
Pharmacologic management of pattern hair loss.
    Facial plastic surgery clinics of North America, 2004, Volume: 12, Issue:2

    Topics: Administration, Topical; Alopecia; Androgen Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finasteride; Humans; Ketoconazole; Male; Minoxidil; Treatment Outcome

2004
[Pathomechanism of androgenetic alopecia and new treatment].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2004, Volume: 41, Issue:6

    Topics: Alopecia; Androgens; Animals; Coculture Techniques; Finasteride; Hair Follicle; Humans; Insulin-Like Growth Factor Binding Protein 1; Keratinocytes; Male; Mice; Minoxidil; Receptors, Androgen; Skin

2004
Androgenetic alopecia and current methods of treatment.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2005, Volume: 14, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Enzyme Inhibitors; Female; Finasteride; Hair; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents

2005
Psychological effect, pathophysiology, and management of androgenetic alopecia in men.
    Mayo Clinic proceedings, 2005, Volume: 80, Issue:10

    Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil

2005
Androgenetic alopecia.
    Endocrinology and metabolism clinics of North America, 2007, Volume: 36, Issue:2

    Topics: Alopecia; Androgens; Comorbidity; Finasteride; Humans; Male; Minoxidil; Models, Biological; Prevalence; Risk Factors; Surgery, Plastic

2007
[Hair follicle regeneration].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:5

    Topics: Alopecia; Animals; Cell- and Tissue-Based Therapy; Dermis; Finasteride; Hair; Hair Follicle; Humans; Minoxidil; Receptors, Androgen; Regeneration; Scalp; Stem Cells

2008
Hair transplantation for men.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2008, Volume: 10, Issue:3

    Topics: Alopecia; Cicatrix; Cosmetic Techniques; Finasteride; Hair; Hair Follicle; Humans; Low-Level Light Therapy; Male; Minoxidil; Scalp

2008
A review of hormonal therapy for female pattern (androgenic) alopecia.
    Dermatology online journal, 2008, Mar-15, Volume: 14, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone

2008
Medical treatments for male and female pattern hair loss.
    Journal of the American Academy of Dermatology, 2008, Volume: 59, Issue:4

    Topics: Adult; Alopecia; Androgen Antagonists; Azasteroids; Drug Therapy, Combination; Dutasteride; Female; Finasteride; Hair; Humans; Hyperhidrosis; Ketoconazole; Male; Minoxidil; Phototherapy; Prostate; Sperm Count; Tretinoin

2008
Androgens and hair loss.
    Current opinion in endocrinology, diabetes, and obesity, 2009, Volume: 16, Issue:3

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgens; Animals; Azasteroids; Dutasteride; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Minoxidil; Risk Factors; Testosterone; Treatment Outcome

2009
Hair loss in women.
    Minerva ginecologica, 2009, Volume: 61, Issue:5

    Topics: Alopecia; Biotin; Contraceptives, Oral, Hormonal; Female; Finasteride; Gonadal Steroid Hormones; Hair Follicle; Humans; Iron; Iron Deficiencies; Minoxidil; Pregnancy; Pregnancy Complications; Puerperal Disorders; Stress, Psychological; Substance Withdrawal Syndrome; Trichotillomania

2009
Hair restoration in the ethnic patient and review of hair transplant fundamentals.
    Facial plastic surgery clinics of North America, 2010, Volume: 18, Issue:1

    Topics: Alopecia; Enzyme Inhibitors; Esthetics; Ethnicity; Finasteride; Hair; Hair Follicle; Humans; Minoxidil

2010
Male androgenetic alopecia.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:8

    Topics: Administration, Oral; Administration, Topical; Alopecia; Androgen Receptor Antagonists; Azasteroids; Combined Modality Therapy; Dutasteride; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Male; Men's Health; Minoxidil; Polymorphism, Genetic; Receptors, Androgen

2010
Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism.
    Southern medical journal, 2010, Volume: 103, Issue:9

    Topics: Alopecia; Androgens; Dermatologic Agents; Drugs, Investigational; Female; Finasteride; Humans; Male; Minoxidil; Off-Label Use; Phototherapy; Tretinoin

2010
From surgery to pharmacology to gene therapy: the past, present, and future of hair restoration.
    Annals of plastic surgery, 2010, Volume: 65, Issue:4

    Topics: Alopecia; Female; Finasteride; Forecasting; Genetic Therapy; Hair; Hair Follicle; Humans; Male; Minoxidil; Pharmaceutical Preparations; Scalp; Treatment Outcome

2010
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
    The British journal of dermatology, 2011, Volume: 165 Suppl 3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Cosmetic Techniques; Female; Finasteride; Hair; Hair Preparations; Humans; Minoxidil; Scalp Dermatoses

2011
Promising therapies for treating and/or preventing androgenic alopecia.
    Skin therapy letter, 2012, Volume: 17, Issue:6

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Laser Therapy; Male; Minoxidil; Sex Factors

2012
Pattern hair loss in men: diagnosis and medical treatment.
    Dermatologic clinics, 2013, Volume: 31, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Azasteroids; Dutasteride; Female; Finasteride; Genetic Predisposition to Disease; Hair Follicle; Humans; Male; Minoxidil; Vasodilator Agents

2013
Hair restoration approaches for early onset male androgenetic alopecia.
    Journal of cosmetic dermatology, 2013, Volume: 12, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Cosmetic Techniques; Drug Therapy, Combination; Dutasteride; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Tissue and Organ Harvesting; Vasodilator Agents

2013
Nonsurgical therapy for hair loss.
    Facial plastic surgery clinics of North America, 2013, Volume: 21, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Azasteroids; Combined Modality Therapy; Dutasteride; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Minoxidil; Sex Factors

2013
Androgenetic alopecia: an evidence-based treatment update.
    American journal of clinical dermatology, 2014, Volume: 15, Issue:3

    Topics: Administration, Oral; Administration, Topical; Alopecia; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Male; Minoxidil; Prevalence; Quality of Life; Sex Factors

2014
Hair loss in women.
    Clinical obstetrics and gynecology, 2015, Volume: 58, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents

2015
Normal and aging hair biology and structure 'aging and hair'.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Aging; Alopecia; Finasteride; Hair; Hair Follicle; Humans; Melanocytes; Minoxidil; Phototherapy; Scalp; Stem Cells; Telomere Shortening; Vasodilator Agents

2015
Androgenetic, diffuse and senescent alopecia in men: practical evaluation and management.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil; Vasodilator Agents

2015
Female pattern hair loss.
    Current problems in dermatology, 2015, Volume: 47

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents

2015
Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.
    The Medical clinics of North America, 2015, Volume: 99, Issue:6

    Topics: Acetylcholine Release Inhibitors; Acne Vulgaris; Algorithms; Alopecia; Anti-Bacterial Agents; Antiperspirants; Benzoyl Peroxide; Botulinum Toxins; Contraceptives, Oral, Hormonal; Dermatologic Agents; Finasteride; Hair Follicle; Humans; Hyperhidrosis; Iontophoresis; Mandelic Acids; Minoxidil; Muscarinic Antagonists; Nails; Retinoids; Spironolactone; Sweat Glands; Sympathectomy

2015
Interventions for female pattern hair loss.
    The Cochrane database of systematic reviews, 2016, May-26, Issue:5

    Topics: Alopecia; Drug Administration Schedule; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Minoxidil; Randomized Controlled Trials as Topic

2016
Guidelines on Hair Restoration for East Asian Patients.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42, Issue:7

    Topics: Asia, Eastern; Asian People; Cosmetic Techniques; Dermatologic Agents; Eyebrows; Female; Finasteride; Hair; Humans; Male; Minoxidil; Practice Guidelines as Topic; Tissue and Organ Harvesting; Transplantation

2016
Multi-therapies in androgenetic alopecia: review and clinical experiences.
    Dermatologic therapy, 2016, Volume: 29, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Administration, Oral; Alopecia; Finasteride; Hair; Humans; Minoxidil; Scalp; Treatment Outcome

2016
The Diagnosis and Treatment of Hair and Scalp Diseases.
    Deutsches Arzteblatt international, 2016, May-27, Volume: 113, Issue:21

    Topics: Alopecia; Combined Modality Therapy; Dermatologic Agents; Diagnosis, Differential; Evidence-Based Medicine; Finasteride; Hair; Hormone Replacement Therapy; Humans; Minoxidil; Scalp Dermatoses; Treatment Outcome

2016
Androgenetic Alopecia: An Update of Treatment Options.
    Drugs, 2016, Volume: 76, Issue:14

    Topics: Alopecia; Androgen Antagonists; Animals; Female; Finasteride; Humans; Male; Minoxidil

2016
[Androgenetic alopecia: What's new in the last two years ?]
    Annales de dermatologie et de venereologie, 2016, Volume: 143, Issue:12S

    Topics: Alopecia; Early Diagnosis; Finasteride; France; Gene Expression Regulation; Genetic Association Studies; Genotype; Guideline Adherence; Histone Deacetylases; Humans; Male; Minoxidil; Receptors, Androgen; Repressor Proteins

2016
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:1

    Topics: Alopecia; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Randomized Controlled Trials as Topic; Treatment Outcome

2017
Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Humans; Low-Level Light Therapy; Minoxidil; Network Meta-Analysis; Platelet-Rich Plasma; Vasodilator Agents

2018
Herbal Medicines For Treatment of Androgenic Alopecia.
    Alternative therapies in health and medicine, 2020, Volume: 26, Issue:4

    Topics: Alopecia; Finasteride; Herbal Medicine; Humans; Minoxidil; Phytotherapy; Plants, Medicinal; Scalp

2020
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.
    Dermatologic therapy, 2019, Volume: 32, Issue:5

    Topics: Adult; Alopecia; Androgen Antagonists; Finasteride; Genetic Predisposition to Disease; Hair; Humans; Low-Level Light Therapy; Male; Middle Aged; Minoxidil; Platelet-Rich Plasma; Prognosis; Risk Assessment; Treatment Outcome

2019
Pediatric androgenetic alopecia: A review.
    Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:5

    Topics: Adolescent; Alopecia; Child; Finasteride; Humans; Incidence; Minoxidil; Retrospective Studies

2021
A review of the treatment of male pattern hair loss
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:5

    Topics: Administration, Oral; Administration, Topical; Alopecia; Dry Needling; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Prostaglandins; Randomized Controlled Trials as Topic; Treatment Outcome

2020
Androgenetic Alopecia in Gender Minority Patients.
    Dermatologic clinics, 2020, Volume: 38, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgens; Dermatologic Agents; Estrogens; Finasteride; Hair Follicle; Humans; Low-Level Light Therapy; Minoxidil; Sex Reassignment Procedures; Sexual and Gender Minorities; Tissue Transplantation; Transgender Persons; Transplantation, Autologous

2020
The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Aesthetic plastic surgery, 2020, Volume: 44, Issue:3

    Topics: Alopecia; Finasteride; Hair; Humans; Minoxidil; Photography; Treatment Outcome

2020
Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality.
    The Journal of dermatological treatment, 2022, Volume: 33, Issue:1

    Topics: Alopecia; Female; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome

2022
Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
    International journal of molecular sciences, 2020, Apr-13, Volume: 21, Issue:8

    Topics: Adult Stem Cells; Alopecia; Combined Modality Therapy; Finasteride; Humans; Minoxidil; Platelet-Rich Plasma; Stem Cell Transplantation; Treatment Outcome

2020
Physiology and Medical Treatments for Alopecia.
    Facial plastic surgery clinics of North America, 2020, Volume: 28, Issue:2

    Topics: Alopecia; Dihydrotestosterone; Dutasteride; Finasteride; Hair Preparations; Humans; Low-Level Light Therapy; Minoxidil

2020
Transdermal Drug Delivery for Hair Regrowth.
    Molecular pharmaceutics, 2021, 02-01, Volume: 18, Issue:2

    Topics: Acrylates; Administration, Cutaneous; Alopecia; Drug Carriers; Finasteride; Hair Follicle; Humans; Janus Kinases; Minoxidil; Nanoparticles; Permeability; Signal Transduction; Skin; STAT Transcription Factors; Transdermal Patch; Valproic Acid

2021
The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
    Dermatologic therapy, 2020, Volume: 33, Issue:4

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Treatment Outcome

2020
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Alopecia; Finasteride; Hair; Humans; Low-Level Light Therapy; Minoxidil

2020
Combination Approaches for Combatting Hair Loss.
    Dermatologic clinics, 2021, Volume: 39, Issue:3

    Topics: Alopecia; Child; Female; Finasteride; Humans; Male; Middle Aged; Minoxidil

2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
    Journal of cosmetic dermatology, 2021, Volume: 20, Issue:12

    Topics: Alopecia; Alopecia Areata; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Quality of Life

2021
Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics.
    Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:4

    Topics: Alopecia; Dutasteride; Finasteride; Humans; Minoxidil; Transgender Persons; Treatment Outcome

2023
Natural products for male androgenetic alopecia.
    Dermatologic therapy, 2022, Volume: 35, Issue:4

    Topics: Alopecia; Biological Products; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2022
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
    JAMA dermatology, 2022, Mar-01, Volume: 158, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Bayes Theorem; Dutasteride; Finasteride; Humans; Male; Minoxidil; Network Meta-Analysis; Treatment Outcome; Young Adult

2022
Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:5

    Topics: Administration, Topical; Alopecia; Clinical Trials, Phase III as Topic; Female; Finasteride; Hair; Humans; Male; Minoxidil; Randomized Controlled Trials as Topic; Tablets; Treatment Outcome

2022
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    The Journal of dermatological treatment, 2022, Volume: 33, Issue:7

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Finasteride; Hair; Humans; Male; Minoxidil

2022
Noninvasive Hair Rejuvenation.
    Facial plastic surgery clinics of North America, 2022, Volume: 30, Issue:3

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Rejuvenation; Treatment Outcome

2022
Advances in microneedles research based on promoting hair regrowth.
    Journal of controlled release : official journal of the Controlled Release Society, 2023, Volume: 353

    Topics: Alopecia; Drug Delivery Systems; Finasteride; Hair; Humans; Minoxidil

2023
Pediatric androgenetic alopecia: an updated review.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2023, Volume: 21, Issue:1

    Topics: Adolescent; Alopecia; Child; Female; Finasteride; Hair; Humans; Minoxidil; Treatment Outcome

2023
A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
    Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 2023, Volume: 32, Issue:7

    Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Postmenopause; Treatment Outcome

2023
Natural Compounds Used for Treating Hair Loss.
    Current pharmaceutical design, 2023, Volume: 29, Issue:16

    Topics: Alopecia; Animals; Bees; Finasteride; Hair; Minoxidil; Plants, Medicinal; Quality of Life; United States

2023
Androgenetic Alopecia: Therapy Update.
    Drugs, 2023, Volume: 83, Issue:8

    Topics: Administration, Oral; Administration, Topical; Alopecia; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2023
Noninvasive Hair Rejuvenation.
    Clinics in plastic surgery, 2023, Volume: 50, Issue:3

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Rejuvenation; Treatment Outcome

2023
Combination therapy in female pattern hair loss.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2023, May-19, Volume: 25, Issue:1-4

    Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Spironolactone; Treatment Outcome

2023
Dissolving microneedles for alopecia treatment.
    Colloids and surfaces. B, Biointerfaces, 2023, Volume: 229

    Topics: Alopecia; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Quality of Life; Treatment Outcome

2023
Medical and procedural treatment of androgenetic alopecia - Where are we?
    Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:2S

    Topics: Alopecia; Behavior Therapy; Dietary Supplements; Finasteride; Humans; Minoxidil

2023
Comparative effects of finasteride and minoxidil on the male reproductive organs: A systematic review of in vitro and in vivo evidence.
    Toxicology and applied pharmacology, 2023, 11-01, Volume: 478

    Topics: Administration, Oral; Adult; Alopecia; Animals; Finasteride; Humans; Male; Mice; Minoxidil; Prostatic Hyperplasia; Treatment Outcome

2023

Trials

13 trial(s) available for minoxidil and finasteride

ArticleYear
Propecia and Rogaine Extra Strength for alopecia.
    The Medical letter on drugs and therapeutics, 1998, Feb-27, Volume: 40, Issue:1021

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Alopecia; Clinical Trials as Topic; Drug Costs; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Male; Middle Aged; Minoxidil; Multicenter Studies as Topic; Vasodilator Agents

1998
Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
    The Journal of dermatology, 2002, Volume: 29, Issue:8

    Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Hair Preparations; Humans; Ketoconazole; Male; Minoxidil

2002
An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
    Dermatology (Basel, Switzerland), 2004, Volume: 209, Issue:2

    Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Alopecia; Analysis of Variance; Dose-Response Relationship, Drug; Drug Administration Schedule; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Minoxidil; Patient Satisfaction; Probability; Reference Values; Statistics, Nonparametric; Treatment Outcome

2004
[Effectiveness of the treatment plan for androgenetic alopecia].
    Georgian medical news, 2007, Issue:145

    Topics: Adolescent; Adult; Alopecia; Antifungal Agents; Chronic Disease; Enzyme Inhibitors; Female; Finasteride; Humans; Ketoconazole; Male; Middle Aged; Minoxidil; Vasodilator Agents; Zinc

2007
Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012, Volume: 95, Issue:10

    Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Double-Blind Method; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Minoxidil; Treatment Outcome; Vasodilator Agents

2012
Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:1

    Topics: Administration, Topical; Alopecia; Angiogenesis Inducing Agents; Double-Blind Method; Drug Therapy, Combination; Female; Finasteride; Humans; Male; Minoxidil; Platelet-Rich Plasma; Treatment Outcome

2018
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:12

    Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Adult; Alopecia; Dihydrotestosterone; Double-Blind Method; Drug Combinations; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Photography; Treatment Outcome; Vasodilator Agents

2018
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    American journal of clinical dermatology, 2019, Volume: 20, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Aged; Alopecia; Dihydrotestosterone; Double-Blind Method; Drug Therapy, Combination; Female; Finasteride; Hair; Humans; Middle Aged; Minoxidil; Postmenopause; Prospective Studies; Treatment Outcome; Vasodilator Agents

2019
Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2020, Volume: 26, Issue:4

    Topics: Administration, Topical; Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Scalp; Treatment Outcome

2020
Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:9

    Topics: Alopecia; Fibroblast Growth Factor 2; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2022
Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:10

    Topics: Administration, Topical; Alopecia; Finasteride; Flutamide; Humans; Minoxidil; Treatment Outcome

2022
Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:10

    Topics: Administration, Topical; Alopecia; Double-Blind Method; Dutasteride; Finasteride; Humans; Minoxidil; Treatment Outcome

2022
A study of combination unilateral subcutaneous botulinum toxin a treatment for androgenetic alopecia.
    Journal of cosmetic dermatology, 2022, Volume: 21, Issue:11

    Topics: Alopecia; Botulinum Toxins, Type A; Finasteride; Humans; Minoxidil; Treatment Outcome

2022

Other Studies

60 other study(ies) available for minoxidil and finasteride

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Androstenes; Animals; Azasteroids; Chromatography, High Pressure Liquid; Dihydrotestosterone; Drug Interactions; Finasteride; Hair; Macaca; Male; Minoxidil; Reference Values; Testosterone

1992
Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Archives of dermatology, 1995, Volume: 131, Issue:12

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Alopecia; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Finasteride; Humans; Keratolytic Agents; Male; Minoxidil; Oxidoreductases; Pharmaceutical Vehicles; Tretinoin; Vasodilator Agents

1995
Hair growth therapy(ies) for androgenetic alopecia.
    Archives of dermatology, 1996, Volume: 132, Issue:6

    Topics: Alopecia; Finasteride; Hair; Humans; Minoxidil; Tretinoin

1996
Human genetics. Hair apparent.
    Nature, 1998, Feb-05, Volume: 391, Issue:6667

    Topics: Alopecia; Animals; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Mice; Minoxidil; Mutation; Proteins; Transcription Factors

1998
Retinoids and hair growth.
    Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:2 Pt 3

    Topics: Alopecia; Animals; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Keratolytic Agents; Male; Minoxidil; Retinoids; Tretinoin; Vasodilator Agents

1998
Authors' conflicts of interest: a disclosure and editors' reply.
    The New England journal of medicine, 1999, Nov-18, Volume: 341, Issue:21

    Topics: Alopecia; Conflict of Interest; Drug Industry; Financial Support; Finasteride; Humans; Minoxidil; Publishing; Research Support as Topic; Review Literature as Topic

1999
Where's the hair?
    Health news (Waltham, Mass.), 1999, Oct-25, Volume: 5, Issue:13

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil

1999
Should men still go bald gracefully?
    Lancet (London, England), 2000, Jan-15, Volume: 355, Issue:9199

    Topics: Alopecia; Enzyme Inhibitors; Finasteride; Hair Follicle; Humans; Male; Minoxidil

2000
[Treatment for hair loss].
    Medizinische Monatsschrift fur Pharmazeuten, 2000, Volume: 23, Issue:6

    Topics: Alopecia; Alopecia Areata; Female; Finasteride; Humans; Male; Minoxidil

2000
[Toward an effective treatment of androgenetic alopecia?].
    Annales de dermatologie et de venereologie, 2000, Volume: 127 Suppl 1

    Topics: Alopecia; Androgens; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2000
[Androgenetic alopecia: drug treatment].
    Annales de dermatologie et de venereologie, 2000, Volume: 127 Suppl 1

    Topics: Administration, Oral; Alopecia; Androgens; Animals; Clinical Trials as Topic; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2000
[Status of scalp hair and therapy of alopecia in men in Switzerland].
    Praxis, 2001, Feb-15, Volume: 90, Issue:7

    Topics: Adolescent; Adult; Aged; Alopecia; Cross-Sectional Studies; Cyclic N-Oxides; Finasteride; Humans; Incidence; Male; Middle Aged; Minoxidil; Patient Acceptance of Health Care; Patient Care Team; Pyrimidines; Switzerland

2001
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
    Health news (Waltham, Mass.), 2002, Volume: 8, Issue:3

    Topics: Alopecia; Diuretics; Enzyme Inhibitors; Female; Finasteride; Humans; Minoxidil; Spironolactone; United States; Vasodilator Agents

2002
[Androgenetic alopecia in the man].
    Therapeutische Umschau. Revue therapeutique, 2002, Volume: 59, Issue:5

    Topics: Adult; Age Factors; Aged; Alopecia; Androgens; Finasteride; Hair; Hair Follicle; Humans; Male; Middle Aged; Minoxidil

2002
[TrichoScan. A new instrument for digital hair analysis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2002, Volume: 53, Issue:12

    Topics: Adult; Alopecia; Female; Finasteride; Follow-Up Studies; Hair; Hair Diseases; Humans; Image Processing, Computer-Assisted; Male; Microscopy; Minoxidil; Sensitivity and Specificity; Treatment Outcome

2002
Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
    Archives of dermatology, 2003, Volume: 139, Issue:9

    Topics: Adolescent; Adult; Alopecia; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Minoxidil; Randomized Controlled Trials as Topic; Vasodilator Agents

2003
Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
    Archives of dermatology, 2003, Volume: 139, Issue:9

    Topics: Administration, Oral; Administration, Topical; Adult; Alopecia; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Substance Withdrawal Syndrome; Vasodilator Agents

2003
[Hair loss].
    Praxis, 2003, Sep-03, Volume: 92, Issue:36

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Alopecia Areata; Biopsy; Child; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Female; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Multicenter Studies as Topic; Placebos; Scalp; Sex Factors; Time Factors

2003
Androgenetic alopecia: combining medical and surgical treatments.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:11

    Topics: Alopecia; Combined Modality Therapy; Enzyme Inhibitors; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Skin Transplantation; Vasodilator Agents

2003
Evaluation and treatment of male and female pattern hair loss.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone

2005
Telling the bald truth.
    Newsweek, 2003, Jun-16, Volume: 141, Issue:24

    Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; United States

2003
Frontal fibrosing alopecia: a survey in 16 patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:6

    Topics: Aged; Alopecia; Diagnosis, Differential; Disease Progression; Enzyme Inhibitors; Eyebrows; Female; Fibrosis; Finasteride; Glucocorticoids; Humans; Middle Aged; Minoxidil; Postmenopause; Scalp Dermatoses; Treatment Outcome

2005
Finasteride and minoxidil for alopecia revisited.
    The Medical letter on drugs and therapeutics, 2005, Nov-21, Volume: 47, Issue:1222

    Topics: Adult; Alopecia; Antihypertensive Agents; Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Middle Aged; Minoxidil

2005
Managing hair loss. Treatments may help.
    Mayo Clinic health letter (English ed.), 2006, Volume: 24, Issue:6

    Topics: Alopecia; Dermatologic Agents; Female; Finasteride; Humans; Male; Minoxidil

2006
Evolution of techniques in hair transplantation: a 12-year perspective.
    Facial plastic surgery : FPS, 2007, Volume: 23, Issue:1

    Topics: Adult; Alopecia; Cosmetic Techniques; Disease Progression; Enzyme Inhibitors; Female; Finasteride; Forecasting; Hair; Hair Follicle; Humans; Male; Marketing of Health Services; Middle Aged; Minoxidil; Scalp; Surgical Flaps; Tissue Expansion

2007
Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.
    The British journal of dermatology, 2010, Volume: 163, Issue:2

    Topics: Adolescent; Adult; Age of Onset; Alopecia; Biopsy; Diagnosis, Differential; Enzyme Inhibitors; Female; Finasteride; Humans; Male; Minoxidil; New York; Prevalence; Retrospective Studies; Scalp; Sex Distribution; Vasodilator Agents; Young Adult

2010
Adolescent androgenic alopecia.
    Cutis, 2011, Volume: 88, Issue:4

    Topics: 5-alpha Reductase Inhibitors; Adolescent; Alopecia; Diagnosis, Differential; Female; Finasteride; Humans; Male; Minoxidil; Vasodilator Agents

2011
Guidelines for the management of androgenetic alopecia (2010).
    The Journal of dermatology, 2012, Volume: 39, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Female; Finasteride; Hair; Humans; Male; Minoxidil; Randomized Controlled Trials as Topic; Vasodilator Agents

2012
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
    Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:1

    Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; Female; Finasteride; Humans; Male; Minoxidil; Neoplasms; Risk Factors; Time Factors

2011
Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.
    International journal of nanomedicine, 2014, Volume: 9

    Topics: Administration, Topical; Alopecia; Animals; Delayed-Action Preparations; Dermatologic Agents; Drug Delivery Systems; Drug Stability; Finasteride; Humans; Lipids; Male; Minoxidil; Nanomedicine; Nanoparticles; Nanotechnology; Particle Size; Skin; Surface Properties; Swine

2014
Increasing utility of finasteride for frontal fibrosing alopecia.
    Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:6

    Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrosis; Finasteride; Follow-Up Studies; Frontal Bone; Humans; Middle Aged; Minoxidil; Sampling Studies; Severity of Illness Index; Treatment Outcome

2015
[Drug treatment of alopecia].
    Der Internist, 2015, Volume: 56, Issue:10

    Topics: Administration, Topical; Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Cyclopropanes; Evidence-Based Medicine; Finasteride; Humans; Minoxidil; Treatment Outcome

2015
Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair.
    Experimental dermatology, 2016, Volume: 25, Issue:6

    Topics: Adult; Alopecia; Female; Finasteride; Hair Follicle; Humans; Male; Minoxidil; Retrospective Studies

2016
Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
    Oncotarget, 2016, Dec-13, Volume: 7, Issue:50

    Topics: 5-alpha Reductase Inhibitors; Adverse Drug Reaction Reporting Systems; Alopecia; Drug-Related Side Effects and Adverse Reactions; Female; Fetus; Finasteride; Gene Expression Regulation; Gene Regulatory Networks; Hair; Humans; Male; Minoxidil; Reproduction; Risk Assessment; Risk Factors; Sex Factors; United States; United States Food and Drug Administration; Uterus

2016
Interventions for Female Pattern Hair Loss.
    JAMA dermatology, 2017, 03-01, Volume: 153, Issue:3

    Topics: Alopecia; Female; Finasteride; Hair; Humans; Minoxidil

2017
Determination of illegal adulteration of dietary supplements with synthetic hair-growth compounds by UPLC and LC-Q-TOF/MS.
    Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2018, Volume: 35, Issue:2

    Topics: Chromatography, High Pressure Liquid; Dietary Supplements; Drug Contamination; Finasteride; Food Contamination; Hair; Minoxidil; Tandem Mass Spectrometry

2018
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Drug Therapy, Combination; Dutasteride; Evidence-Based Medicine; Female; Finasteride; Hair; Humans; Low-Level Light Therapy; Male; Minoxidil; Outcome Assessment, Health Care; Platelet-Rich Plasma; Practice Guidelines as Topic; Vasodilator Agents

2018
Development and validation of rapid and simultaneous method for determination of 12 hair-growth compounds in adulterated products by UHPLC-MS/MS.
    Forensic science international, 2018, Volume: 284

    Topics: Chromatography, High Pressure Liquid; Consumer Product Safety; Drug Contamination; Finasteride; Hair Preparations; Humans; Limit of Detection; Methyltestosterone; Minoxidil; Reproducibility of Results; Tandem Mass Spectrometry; Testosterone Propionate

2018
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
    The Journal of dermatology, 2018, Volume: 45, Issue:9

    Topics: Adenosine; Administration, Oral; Administration, Topical; Alopecia; Dutasteride; Female; Finasteride; Hair; Humans; Japan; Lasers, Semiconductor; Low-Level Light Therapy; Male; Minoxidil; Sex Factors; Treatment Outcome

2018
Platelet rich plasma for the management of hair loss: Better alone or in combination?
    Journal of cosmetic dermatology, 2019, Volume: 18, Issue:2

    Topics: Alopecia; Cell- and Tissue-Based Therapy; Combined Modality Therapy; Finasteride; Hair Follicle; Humans; Injections, Intradermal; Minoxidil; Platelet-Rich Plasma; Treatment Outcome

2019
Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Dermatologic therapy, 2019, Volume: 32, Issue:2

    Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Administration, Topical; Alopecia; Finasteride; Hair; Humans; Male; Middle Aged; Minoxidil; Treatment Outcome; Vasodilator Agents

2019
Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
    Journal of cosmetic dermatology, 2020, Volume: 19, Issue:1

    Topics: Administration, Oral; Administration, Topical; Alopecia; Combined Modality Therapy; Finasteride; Humans; Male; Mesotherapy; Middle Aged; Minoxidil; Treatment Outcome

2020
Reply to: "Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation".
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1

    Topics: Alopecia; Documentation; Finasteride; Humans; Male; Minoxidil

2020
Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation.
    Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:1

    Topics: Alopecia; Documentation; Finasteride; Humans; Male; Minoxidil

2020
Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia.
    Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2020, Jul-03, Volume: 22, Issue:4-5

    Topics: Adolescent; Adult; Alopecia; Finasteride; Hair; Humans; Minoxidil; Platelet-Rich Plasma; Treatment Outcome; Young Adult

2020
Development, validation, and application of an RP-HPLC method for concurrent quantification of Minoxidil and Finasteride in a topical solution for hair regrowth.
    Annales pharmaceutiques francaises, 2021, Volume: 79, Issue:2

    Topics: Chromatography, High Pressure Liquid; Finasteride; Indicators and Reagents; Lipids; Minoxidil

2021
Development and Qualification of a Physiologically Based Pharmacokinetic Model of Finasteride and Minoxidil Following Scalp Application.
    Journal of pharmaceutical sciences, 2021, Volume: 110, Issue:5

    Topics: Finasteride; Minoxidil; Models, Biological; Scalp

2021
"Comparison of QR 678
    Journal of cosmetic dermatology, 2021, Volume: 20, Issue:6

    Topics: Alopecia; Combined Modality Therapy; Finasteride; Hair; Humans; Male; Minoxidil

2021
Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
    Dermatologic therapy, 2022, Volume: 35, Issue:2

    Topics: Alopecia; Edema; Female; Finasteride; Humans; Male; Mesotherapy; Minoxidil; Retrospective Studies; Treatment Outcome

2022
Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil.
    Journal of the American Academy of Dermatology, 2022, Volume: 87, Issue:6

    Topics: Administration, Topical; Alopecia; Blood Pressure Monitoring, Ambulatory; Controlled Before-After Studies; Finasteride; Humans; Minoxidil; Treatment Outcome

2022
What's New in Therapy for Male Androgenetic Alopecia?
    American journal of clinical dermatology, 2023, Volume: 24, Issue:1

    Topics: Alopecia; Dutasteride; Finasteride; Humans; Male; Minoxidil; Retrospective Studies; Treatment Outcome

2023
Digital health platforms expand access and improve care for male androgenetic alopecia.
    International journal of dermatology, 2023, Volume: 62, Issue:2

    Topics: Alopecia; Finasteride; Hair; Humans; Male; Minoxidil; Treatment Outcome

2023
Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic Alopecia.
    Journal of drugs in dermatology : JDD, 2022, Nov-01, Volume: 21, Issue:11

    Topics: Alopecia; Female; Finasteride; Humans; Lasers, Solid-State; Male; Minoxidil; Platelet-Rich Plasma; Treatment Outcome

2022
Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia.
    Journal of drugs in dermatology : JDD, 2023, Jun-01, Volume: 22, Issue:6

    Topics: Alopecia; Drug Administration Schedule; Female; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2023
Investigation of oral finasteride enhanced occipital hair diameter index in different types of male androgenetic alopecia.
    Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Alopecia; Finasteride; Hair; Humans; Male; Minoxidil

2023
Inverse androgenic alopecia.
    BMJ case reports, 2023, Oct-31, Volume: 16, Issue:10

    Topics: Alopecia; Androgen Antagonists; Finasteride; Humans; Male; Minoxidil; Treatment Outcome

2023